1. Home
  2. SMX vs GNPX Comparison

SMX vs GNPX Comparison

Compare SMX & GNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SMX
  • GNPX
  • Stock Information
  • Founded
  • SMX N/A
  • GNPX 2009
  • Country
  • SMX Ireland
  • GNPX United States
  • Employees
  • SMX N/A
  • GNPX N/A
  • Industry
  • SMX Industrial Machinery/Components
  • GNPX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SMX Technology
  • GNPX Health Care
  • Exchange
  • SMX Nasdaq
  • GNPX Nasdaq
  • Market Cap
  • SMX 6.7M
  • GNPX 6.6M
  • IPO Year
  • SMX N/A
  • GNPX 2018
  • Fundamental
  • Price
  • SMX $4.20
  • GNPX $0.23
  • Analyst Decision
  • SMX
  • GNPX
  • Analyst Count
  • SMX 0
  • GNPX 0
  • Target Price
  • SMX N/A
  • GNPX N/A
  • AVG Volume (30 Days)
  • SMX 33.2K
  • GNPX 3.6M
  • Earning Date
  • SMX 01-01-0001
  • GNPX 08-08-2025
  • Dividend Yield
  • SMX N/A
  • GNPX N/A
  • EPS Growth
  • SMX N/A
  • GNPX N/A
  • EPS
  • SMX N/A
  • GNPX N/A
  • Revenue
  • SMX N/A
  • GNPX N/A
  • Revenue This Year
  • SMX N/A
  • GNPX N/A
  • Revenue Next Year
  • SMX N/A
  • GNPX N/A
  • P/E Ratio
  • SMX N/A
  • GNPX N/A
  • Revenue Growth
  • SMX N/A
  • GNPX N/A
  • 52 Week Low
  • SMX $3.60
  • GNPX $0.20
  • 52 Week High
  • SMX $1,308.64
  • GNPX $3.97
  • Technical
  • Relative Strength Index (RSI)
  • SMX 37.98
  • GNPX 40.22
  • Support Level
  • SMX $3.60
  • GNPX $0.22
  • Resistance Level
  • SMX $5.28
  • GNPX $0.32
  • Average True Range (ATR)
  • SMX 0.51
  • GNPX 0.03
  • MACD
  • SMX 0.04
  • GNPX -0.01
  • Stochastic Oscillator
  • SMX 31.52
  • GNPX 22.07

About SMX SMX (Security Matters) Public Limited Company

SMX (Security Matters) PLC provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader, and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer.

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

Share on Social Networks: